USA - New York Stock Exchange - NYSE:CVS - US1266501006 - Common Stock
The current stock price of CVS is 78 USD. In the past month the price decreased by -4.76%. In the past year, price increased by 34.51%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CI | THE CIGNA GROUP | 9.73 | 73.84B | ||
| LH | LABCORP HOLDINGS INC | 16.75 | 21.97B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.57 | 21.35B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 108.86 | 19.67B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.72B | ||
| DVA | DAVITA INC | 13.11 | 8.65B | ||
| HIMS | HIMS & HERS HEALTH INC | 65.91 | 8.04B | ||
| CHE | CHEMED CORP | 20.04 | 6.42B | ||
| RDNT | RADNET INC | 217.55 | 6.36B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 34.94 | 6.31B | ||
| OPCH | OPTION CARE HEALTH INC | 19.78 | 4.78B | ||
| WGS | GENEDX HOLDINGS CORP | 78.42 | 4.24B |
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. The company is headquartered in Woonsocket, Rhode Island and currently employs 300,000 full-time employees. The firm's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.
CVS HEALTH CORP
One Cvs Dr.
Woonsocket RHODE ISLAND 02895 US
CEO: Karen S. Lynch
Employees: 259500
Phone: 14017651500
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. The company is headquartered in Woonsocket, Rhode Island and currently employs 300,000 full-time employees. The firm's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.
The current stock price of CVS is 78 USD. The price decreased by -0.04% in the last trading session.
CVS HEALTH CORP (CVS) has a dividend yield of 3.5%. The yearly dividend amount is currently 2.65.
CVS has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
34 analysts have analysed CVS and the average price target is 92.47 USD. This implies a price increase of 18.56% is expected in the next year compared to the current price of 78.
CVS HEALTH CORP (CVS) has a market capitalization of 98.93B USD. This makes CVS a Large Cap stock.
You can find the ownership structure of CVS HEALTH CORP (CVS) on the Ownership tab.
ChartMill assigns a technical rating of 7 / 10 to CVS. When comparing the yearly performance of all stocks, CVS is one of the better performing stocks in the market, outperforming 88.04% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to CVS. CVS may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months CVS reported a non-GAAP Earnings per Share(EPS) of 6.85. The EPS increased by 7.87% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.12% | ||
| ROA | 0.18% | ||
| ROE | 0.64% | ||
| Debt/Equity | 0.85 |
34 analysts have analysed CVS and the average price target is 92.47 USD. This implies a price increase of 18.56% is expected in the next year compared to the current price of 78.
For the next year, analysts expect an EPS growth of 21.57% and a revenue growth 7.03% for CVS